![]() |
|
|
Forward to a colleague |
||
Access Full Stories SAFC has announced its plans to build a new high potency conjugation suite at its Missouri manufacturing plant in order to target pharma clients developing novel anti-cancer drug conjugates... Read CRO supremacy in clinical research raises concerns While contract research organisations (CROs) now dominate the clinical trials market, questions are being raised about the risks of 'commercialising' clinical studies, according to new research... Read Sprinkles help the medicine go down US regulators have found a new 'hundreds and thousands'-like drug treatment to be very palatable... Read Recordati adopts Orphan Europe Eighty-year-old Italian pharma company Recordati believes its future lies in rare diseases and has put its money where its mouth is by spending €135m on speciality firm Orphan Europe... Read Discovery Labs finally sorts out manufacturing issues Discovery Laboratories could see the end of its struggle to launch its Surfaxin (lucinactant) drug on the US market as it has finally resolved the manufacturing issues that have plagued the product for months... Read |
|||||||||
All News Headlines for: October | September | August |
|||||||||
![]() DPT - The Industry Source for Semi-solids and Liquids. DPT is a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms providing solutions from concept to commercialization. Click here to meet with DPT at CPhI/ICSE... Click Here | |||||||||
|
Related Industry News Sperm stopped in their tracks by vaginal gel contraceptive Forget diamonds, a new vaginal gel contraceptive could be the 21st Century girl's new best friend with the ability to be applied up to 18 hours before a naughty rendezvous... Read BMS takeover speculation mounts, again Investors in Bristol-Myers Squibb were in a frisson of excitement earlier this week as speculation mounted - not for the first time - that the firm could soon become the target of a major pharmaceutical acquisition... Read PDL BioPharma for sale: one careful owner? PDL BioPharma's board has decided to scrap its restructuring plan and put the tormented company for sale, giving in to recent shareholders' pressure... Read Pharmaceutical manufacturing: people on the move Mylan, Momenta Pharmaceuticals, VaxGen, Osprey Pharmaceuticals, Bioject Medical Technologies, and Othera Pharmaceuticals have all had people on the move in the world of pharmaceutical manufacturing... Read
|
|||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||